Fig. 6
From: Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis
Forest plot of the relative risks for adverse events at the end of treatment or during follow-up
Fig. 6 | BMC Nephrology
From: Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis
Forest plot of the relative risks for adverse events at the end of treatment or during follow-up